Archives of Physical Medicine and Rehabilitation
Volume 89, Issue 8 , Pages 1460-1467 , August 2008

Disparities in Antihypertensive Medication Adherence in Persons With Disabilities and Without Disabilities: Results of a Korean Population-Based Study

  • Jong Hyock Park, MD, MPH

      Affiliations

    • Cancer Policy and Management Branch, National Cancer Center, Cheju, Korea
    • ,
  • Jae Hyun Park, MD, PhD, MPH

      Affiliations

    • Cancer Policy and Management Branch, National Cancer Center, Cheju, Korea
    • Corresponding Author InformationReprint requests to Jae Hyun Park, MD, PhD, MPH, National Cancer Center, 809 Madu1-dong, Ilsandong-gu, Goyang-si, Gyeonggi-do, 410-769, Korea
    • ,
  • Sang Yi Lee, MD, PhD

      Affiliations

    • Department of Preventive Medicine, Cheju University College of Medicine, Cheju, Korea
    • ,
  • So Young Kim, MD

      Affiliations

    • Department of Healthcare Industry, Korea Health Industry Development Institute, Seoul, Korea
    • Department of Health Policy and Management, Seoul National University College of Medicine, Seoul, Korea
    • ,
  • Youngsoo Shin, MD, DrPH, MPH

      Affiliations

    • Department of Health Policy and Management, Seoul National University College of Medicine, Seoul, Korea
    • ,
  • Su Young Kim, PhD

      Affiliations

    • Department of Preventive Medicine, Cheju University College of Medicine, Jeju, Korea.

References 

  1. Joint National Committee. The sixth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1997;157:2413–2446
  2. DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care. 2002;40:794–811
  3. DeJong G, Plasbo SE, Beatty PW, Jones GC, Kroll T, Neri MT. The organization and financing of health services for persons with disability. Milbank Q. 2002;80:261–301
  4. Sutton JP, Dejong G. Managed care and people with disability: framing the issues. Arch Phys Med Rehabil. 1998;79:1312–1316
  5. Beatty PW, Hagglund KJ, Neri MT, Dhont KR, Clark MJ, Hilton SA. Access to health care services among people with chronic or disabling conditions: patterns and predictors. Arch Phys Med Rehabil. 2003;84:1417–1425
  6. Lawthers AG, Pransky GS, Peterson LE, Himmelstein JH. Rethinking quality in the context of persons with disability. Int J Qual Health Care. 2003;15:274–299
  7. Iezzoni LI, McCarthy EP, Davis RB, Siebens H. Mobility impairments and use of screening and preventive services. Am J Public Health. 2000;90:955–961
  8. Cumella S, Ransford N, Lyons J, Burnham H. Needs for oral care among people with intellectual disability not in contact with community dental services. J Intellect Disabil Res. 2000;44:45–52
  9. Nosé M, Barbui C, Tansella M. How often do patients with psychosis fail to adhere to treatment programmes? (A systematic review). Psychol Med. 2003;33:1149–1160
  10. Byun YC, Kim SH, Yun SY. National survey for people with disability in South Korea. Seoul: Korean Institute for Health and Social Affairs; 2006;
  11. Steiner JF, Prochazka AV. The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol. 1997;50:105–116
  12. Rudd P. Clinicians and patients with hypertension: unsettled issues about compliance. Am Heart J. 1995;130:572–579
  13. Sackett DL, Haynes RB, Gibson ES, et al. Randomised clinical trial of strategies for improving medication compliance in primary hypertension. Lancet. 1975;1:1205–1207
  14. Haynes RB, Taylor DW, Sackett DL. Compliance in health care. Baltimore: Johns Hopkins Univ Pr; 1979;
  15. Eraker SA, Kirscht JP, Becker MH. Understanding and improving patient compliance. Ann Intern Med. 1984;100:258–268
  16. Steiner JF, Fihn SD, Blair B, Inui TS. Appropriate reductions in compliance among well-controlled hypertensive patients. J Clin Epidemiol. 1991;44:1361–1371
  17. Caro JJ, Speckman JL, Salas M, Raggio G, Jackson JD. Persistence with treatment for hypertension in actual practice. CMAJ. 1999;160:31–37
  18. Marentette MA, Gerth WC, Billings DK, Zarnke KB. Antihypertensive persistence and drug class. Can J Cardiol. 2002;18:649–656
  19. Shea S, Misra D, Ehrlich MH, Field L, Francis CK. Correlates of nonadherence to hypertension treatment in an inner-city minority population. Am J Public Health. 1992;82:1607–1612
  20. Monane M, Bohn RL, Gurwitz JH, Glynn RJ, Levin R, Avorn J. Compliance with antihypertensive therapy: role of age, gender and race. Am J Public Health. 1996;86:1805–1809
  21. Grant RW, Singer DE, Meigs JB. Medication adherence before an increase in antihypertensive therapy: a cohort study using pharmacy claims data. Clin Ther. 2005;27:773–781
  22. McComhs JS, Nichol MB, Newman CM, Sclar DA. The costs of interrupting antihypertensive drug therapy in a medical population. Med Care. 1994;32:214–226
  23. Park JH, Shin Y, Lee SY, Lee SI. Antihypertensive drug medication adherence and its affecting factors in South Korea. Int J Cardiol. In press.
  24. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560–2572
  25. Havercamp SM, Scandlin D, Roth M. Health disparities among adults with developmental disability, adults with other disability, and adults not reporting disability in North Carolina. Public Health Rep. 2004;119:418–426
  26. Park JH, Lee JS, Lee JY, et al. [Factors affecting National Health Insurance mass screening participation in the disabled] [Korean]. J Prev Med Public Health. 2006;39:511–519
  27. Dejong G. An overview of the problem: primary care for persons with disability supplement: introduction. Am J Phys Med Rehabil. 1997;76:S2–S8
  28. Patrick DL. Rethinking prevention for people with disability, part I: a conceptual model for promoting health. Am J Health Promot. 1997;11:257–260
  29. Iezzoni LI, Davis RB, Soukup J, O'Day B. Quality dimensions that most concern people with physical and sensory disability. Arch Intern Med. 2003;163:2085–2092
  30. Eun SJ, Hong JY, Lee JY, et al. [Differences in medical care utilization rates of disabled and the non-disabled with ambulatory care sensitive conditions] [Korean]. J Prev Med Public Health. 2006;39:411–418
  31. Grabois EW, Nosek MA, Rossi CD. Accessibility of primary care physicians' offices for people with disability: an analysis of compliance with the Americans with Disability Act. Arch Fam Med. 1999;8:44–51
  32. Denson CR. Public sector transportation for people with disability: a satisfaction survey. J Rehabil. 2000;66:29–37
  33. Ebert DA, Heckerling PS. Communication with deaf patients: knowledge, beliefs, and practices of physicians. JAMA. 1995;273:227–229
  34. Ebert DA, Heckerling PS. Communication disability among medical inpatients. N Engl J Med. 1998;339:272–273
  35. Rivadeneyra R, Elderkin-Thompson V, Silver RC, Waitzkin HM. Patient centeredness in medical encounters requiring an interpreter. Am J Med. 2000;108:470–474
  36. Dolder CR, Furtek K, Lacro JP, Jeste DV. Antihypertensive medication adherence and blood pressure control in patients with psychotic disorders compared to persons without psychiatric illness. Psychosomatics. 2005;46:135–141
  37. Burton WN, Chen CY, Conti DJ, Schultz AB, Edington DW. The association of antidepressant medication adherence with employee disability absences. Am J Manag Care. 2007;13:105–112
  38. Lennox N, Chaplin R. The psychiatric care of people with intellectual disability: the perceptions of trainee psychiatrists and psychiatric medical officers. Aust N Z J Psychiatry. 1995;29:632–637
  39. Wandless I, Mucklow JC, Smith A, Prudham D. Compliance with prescribed medicines: a study of elderly patients in the community. J R Coll Gen Pract. 1979;29:391–396
  40. Cramer JA, Mattson RH, Prevey ML, Scheyer RD, Ouellette VL. How often is medication taken as prescribed? (A novel assessment technique). JAMA. 1989;261:3273–3277
  41. Krousel-Wood M, Thomas S, Muntner P, Morisky D. Medication adherence: a key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients. Curr Opin Cardiol. 2004;19:357–362

 No commercial party having a direct financial interest in the results of the research supporting this article has or will confer a benefit upon the authors or upon any organization with which the authors are associated.

PII: S0003-9993(08)00380-8

doi: 10.1016/j.apmr.2007.12.045

Archives of Physical Medicine and Rehabilitation
Volume 89, Issue 8 , Pages 1460-1467 , August 2008

Article Tools